Annual Working Capital
$184.82 M
-$86.59 M-31.90%
December 31, 2022
Summary
- As of February 10, 2025, GRCL annual working capital is $184.82 million, with the most recent change of -$86.59 million (-31.90%) on December 31, 2022.
- During the last 3 years, GRCL annual working capital has risen by +$138.77 million (+301.36%).
Performance
GRCL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$211.72 M
+$66.48 M+45.77%
September 30, 2023
Summary
- As of February 10, 2025, GRCL quarterly working capital is $211.72 million, with the most recent change of +$66.48 million (+45.77%) on September 30, 2023.
- Over the past year, GRCL quarterly working capital has increased by +$66.48 million (+45.77%).
Performance
GRCL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
GRCL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.9% | +45.8% |
| 3 y3 years | +301.4% | +45.8% |
| 5 y5 years | +954.9% | +45.8% |
GRCL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.9% | at low | -22.0% | -31.4% |
| 5 y | 5-year | -31.9% | -75.1% | -33.7% | -87.3% |
| alltime | all time | -31.9% | -90.5% | -33.7% | -87.3% |
Gracell Biotechnologies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $211.72 M(+45.8%) |
| Jun 2023 | - | $145.25 M(-10.2%) |
| Mar 2023 | - | $161.76 M(-12.5%) |
| Dec 2022 | $184.82 M(-31.9%) | $184.82 M(-7.5%) |
| Sep 2022 | - | $199.75 M(-12.1%) |
| Jun 2022 | - | $227.13 M(-8.3%) |
| Mar 2022 | - | $247.60 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $271.40 M(+145.6%) | $271.40 M(-6.6%) |
| Sep 2021 | - | $290.68 M(-5.3%) |
| Jun 2021 | - | $306.99 M(-3.9%) |
| Mar 2021 | - | $319.56 M(+189.1%) |
| Dec 2020 | $110.53 M(+140.0%) | $110.53 M(+311.2%) |
| Sep 2020 | - | $26.88 M(-41.6%) |
| Dec 2019 | $46.05 M(+162.8%) | $46.05 M |
| Dec 2018 | $17.52 M | - |
FAQ
- What is Gracell Biotechnologies annual working capital?
- What is the all time high annual working capital for Gracell Biotechnologies?
- What is Gracell Biotechnologies annual working capital year-on-year change?
- What is Gracell Biotechnologies quarterly working capital?
- What is the all time high quarterly working capital for Gracell Biotechnologies?
- What is Gracell Biotechnologies quarterly working capital year-on-year change?
What is Gracell Biotechnologies annual working capital?
The current annual working capital of GRCL is $184.82 M
What is the all time high annual working capital for Gracell Biotechnologies?
Gracell Biotechnologies all-time high annual working capital is $271.40 M
What is Gracell Biotechnologies annual working capital year-on-year change?
Over the past year, GRCL annual working capital has changed by -$86.59 M (-31.90%)
What is Gracell Biotechnologies quarterly working capital?
The current quarterly working capital of GRCL is $211.72 M
What is the all time high quarterly working capital for Gracell Biotechnologies?
Gracell Biotechnologies all-time high quarterly working capital is $319.56 M
What is Gracell Biotechnologies quarterly working capital year-on-year change?
Over the past year, GRCL quarterly working capital has changed by +$66.48 M (+45.77%)